Phibro Animal Health Corporation
PAHC
$47.92
-$1.67-3.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.39% | 33.71% | 27.37% | 19.12% | 12.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.39% | 33.71% | 27.37% | 19.12% | 12.63% |
| Cost of Revenue | 31.80% | 33.35% | 26.49% | 15.80% | 10.09% |
| Gross Profit | 33.64% | 34.50% | 29.34% | 26.75% | 18.44% |
| SG&A Expenses | 16.09% | 15.38% | 8.32% | 22.63% | 18.99% |
| Depreciation & Amortization | -20.46% | -20.46% | -20.46% | -1.94% | -1.94% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.75% | 28.69% | 21.64% | 14.27% | 9.12% |
| Operating Income | 78.09% | 90.09% | 113.42% | 90.47% | 64.95% |
| Income Before Tax | 273.59% | 191.07% | 522.87% | 94.82% | 20.11% |
| Income Tax Expenses | 135.90% | 77.54% | 132.11% | 46.73% | 8.54% |
| Earnings from Continuing Operations | 376.73% | 289.61% | 1,897.68% | 141.54% | 30.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 376.73% | 289.61% | 1,897.68% | 141.54% | 30.53% |
| EBIT | 78.09% | 90.09% | 113.42% | 90.47% | 64.95% |
| EBITDA | 65.52% | 74.93% | 82.93% | 65.93% | 46.53% |
| EPS Basic | 376.49% | 289.39% | 1,895.64% | 141.45% | 30.51% |
| Normalized Basic EPS | 147.47% | 134.28% | 349.68% | 154.05% | 71.91% |
| EPS Diluted | 375.10% | 290.50% | 2,010.34% | 141.82% | 31.21% |
| Normalized Diluted EPS | 146.32% | 133.20% | 348.51% | 153.09% | 71.46% |
| Average Basic Shares Outstanding | 0.05% | 0.03% | 0.01% | 0.01% | 0.00% |
| Average Diluted Shares Outstanding | 0.51% | 0.49% | 0.36% | 0.36% | 0.25% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.79% | -0.74% | -0.95% | -0.59% | -0.23% |